COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 195 industry peers in the Pharmaceuticals industry. While COLL has a great profitability rating, there are some minor concerns on its financial health. COLL may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
In the past year COLL had a positive cash flow from operations.
Of the past 5 years COLL 4 years were profitable.
COLL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
COLL has a Return On Assets of 2.69%. This is amongst the best in the industry. COLL outperforms 84.62% of its industry peers.
COLL's Return On Equity of 18.72% is amongst the best of the industry. COLL outperforms 91.28% of its industry peers.
The Return On Invested Capital of COLL (8.30%) is better than 86.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COLL is below the industry average of 14.87%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROIC | 8.3% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
The Profit Margin of COLL (6.61%) is better than 84.62% of its industry peers.
In the last couple of years the Profit Margin of COLL has declined.
COLL's Operating Margin of 21.39% is amongst the best of the industry. COLL outperforms 88.21% of its industry peers.
COLL's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 57.69%, COLL is doing good in the industry, outperforming 67.18% of the companies in the same industry.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so COLL is still creating some value.
Compared to 1 year ago, COLL has less shares outstanding
The number of shares outstanding for COLL has been reduced compared to 5 years ago.
The debt/assets ratio for COLL has been reduced compared to a year ago.
2.2 Solvency
COLL has an Altman-Z score of 1.01. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.01, COLL is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of COLL is 4.26, which is a neutral value as it means it would take COLL, 4.26 years of fcf income to pay off all of its debts.
COLL has a better Debt to FCF ratio (4.26) than 85.64% of its industry peers.
COLL has a Debt/Equity ratio of 3.30. This is a high value indicating a heavy dependency on external financing.
COLL has a worse Debt to Equity ratio (3.30) than 81.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 1.01 |
ROIC/WACC0.88
WACC9.49%
2.3 Liquidity
COLL has a Current Ratio of 1.08. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
COLL has a worse Current ratio (1.08) than 80.51% of its industry peers.
COLL has a Quick Ratio of 1.01. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
COLL has a Quick ratio of 1.01. This is in the lower half of the industry: COLL underperforms 75.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 106.69% over the past year.
The Earnings Per Share has been growing by 154.78% on average over the past years. This is a very strong growth
COLL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.18%.
The Revenue has been growing by 16.31% on average over the past years. This is quite good.
EPS 1Y (TTM)106.69%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%2.76%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%22.66%
3.2 Future
COLL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.69% yearly.
The Revenue is expected to grow by 2.64% on average over the next years.
EPS Next Y23.61%
EPS Next 2Y12%
EPS Next 3Y5.6%
EPS Next 5Y7.69%
Revenue Next Year18.09%
Revenue Next 2Y10.81%
Revenue Next 3Y4.68%
Revenue Next 5Y2.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 4.70, the valuation of COLL can be described as very cheap.
COLL's Price/Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 97.44% of the companies in the same industry.
COLL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.28.
With a Price/Forward Earnings ratio of 3.77, the valuation of COLL can be described as very cheap.
95.90% of the companies in the same industry are more expensive than COLL, based on the Price/Forward Earnings ratio.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.7 | ||
| Fwd PE | 3.77 |
4.2 Price Multiples
97.95% of the companies in the same industry are more expensive than COLL, based on the Enterprise Value to EBITDA ratio.
COLL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. COLL is cheaper than 97.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.99 | ||
| EV/EBITDA | 4.57 |
4.3 Compensation for Growth
COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of COLL may justify a higher PE ratio.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y12%
EPS Next 3Y5.6%
5. Dividend
5.1 Amount
COLL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.51
+0.21 (+0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners116.69%
Inst Owner Change-1.07%
Ins Owners1.52%
Ins Owner Change3.9%
Market Cap980.59M
Analysts81.82
Price Target43.86 (43.76%)
Short Float %15.26%
Short Ratio16.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.4%
Min EPS beat(2)1.96%
Max EPS beat(2)12.85%
EPS beat(4)3
Avg EPS beat(4)5.22%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)13.83%
EPS beat(12)8
Avg EPS beat(12)-13.44%
EPS beat(16)8
Avg EPS beat(16)-30.16%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.62%
Revenue beat(16)6
Avg Revenue beat(16)-5.22%
PT rev (1m)0.47%
PT rev (3m)0.47%
EPS NQ rev (1m)13.42%
EPS NQ rev (3m)12.72%
EPS NY rev (1m)13.45%
EPS NY rev (3m)19.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.74%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.7 | ||
| Fwd PE | 3.77 | ||
| P/S | 1.48 | ||
| P/FCF | 4.99 | ||
| P/OCF | 4.94 | ||
| P/B | 4.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.57 |
EPS(TTM)6.49
EY21.27%
EPS(NY)8.09
Fwd EY26.52%
FCF(TTM)6.12
FCFY20.04%
OCF(TTM)6.17
OCFY20.24%
SpS20.67
BVpS7.29
TBVpS-23.41
PEG (NY)0.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROCE | 12.41% | ||
| ROIC | 8.3% | ||
| ROICexc | 10.04% | ||
| ROICexgc | N/A | ||
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% | ||
| FCFM | 29.59% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 0.99% | ||
| Cap/Sales | 0.28% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 59.7% | ||
| Profit Quality | 447.8% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.01 |
F-Score4
WACC9.49%
ROIC/WACC0.88
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.69%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%2.76%
EPS Next Y23.61%
EPS Next 2Y12%
EPS Next 3Y5.6%
EPS Next 5Y7.69%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%22.66%
Revenue Next Year18.09%
Revenue Next 2Y10.81%
Revenue Next 3Y4.68%
Revenue Next 5Y2.64%
EBIT growth 1Y-25.89%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year146.84%
EBIT Next 3Y28.51%
EBIT Next 5Y14.2%
FCF growth 1Y12%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y11.99%
OCF growth 3Y25.54%
OCF growth 5Y49.12%